Table 3 Description of administered antibiotics in patients receiving adequate treatment
Adequate monotherapy | ||
|---|---|---|
|  | Empirical (n = 103) | Targeted (n = 141) |
ß-lactam | 88 (85.4%) | 114 (80.9%) |
 Antipseudomonal penicillin | 24 (23.3%) | 31 (21.9%) |
 Cephalosporin | 45 (43.7%) | 36 (25.5%) |
 Carbapenem | 19 (18.4%) | 47 (33.3%) |
Fluoroquinolones | 8 (7.8%) | 20 (14.2%) |
Colistin | 7 (6.8%) | 7 (4.9%) |
Adequate combination therapy | ||
|  | Empirical (n = 38) | Targeted (n = 42) |
ß-lactam + aminoglycosides | 32 (84.2%) | 33 (78.6%) |
 Antipseudomonal penicillin | 6 (68.4%) | 25 (59.6%) |
 Cephalosporin | 26 (15.8%) | 3 (7.1%) |
 Carbapenem | 0 | 5 (11.9%) |
ß-lactam + fluoroquinolones | 5 (13.2%) | 7 (16.7%) |
 Antipseudomonal penicillin | 3 (7.9%) | 2 (4.8%) |
 Cephalosporin | 2 (5.3%) | 4 (9.5%) |
 Carbapenem | 0 | 1 (2.4%) |
Colistin + fluoroquinolones | 1 (2.6%) | 1 (2.4%) |
Colistin + aminoglycoside | 0 | 1 (2.4%) |